Oana-Maria Rosu, Nicoleta Gimiga, Roxana Popescu, Ileana Ioniuc, Carmen Daniela Rusu, Tatiana Clipa, Diana-Maria Florea, Doina-Anca Pleșca, Alexandru Nemtoi, Elena Tataranu and 2 more
Article in Children (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 6 institutions in 1 country.
Oana-Maria RosuDoctoral School, "George Emil Palade" University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 38 Gheorghe Marinescu Str., 540139 Targu Mures, Romania.
Nicoleta GimigaFaculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Str., 700115 Iasi, Romania.ORCID 0000-0002-8713-5367
Roxana PopescuFaculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Str., 700115 Iasi, Romania.ORCID 0000-0002-2183-0690
Ileana IoniucFaculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Str., 700115 Iasi, Romania.
Carmen Daniela RusuFaculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Str., 700115 Iasi, Romania.
Tatiana ClipaMedical Genetics Department, "Cuza Voda" Clinical Hospital of Obstetrics and Gynecology, 34 Cuza Voda Str., 700038 Iasi, Romania.
Diana-Maria FloreaMedical Genetics Department, "Cuza Voda" Clinical Hospital of Obstetrics and Gynecology, 34 Cuza Voda Str., 700038 Iasi, Romania.
Doina-Anca PleșcaFaculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 21 Dionisie Lupu Str., 020021 Bucharest, Romania.
Alexandru NemtoiFaculty of Medicine and Biological Sciences, "Stefan cel Mare" University of Suceava, 13 Universitatii Str., 720229 Suceava, Romania.ORCID 0000-0002-4376-4874
Elena TataranuFaculty of Medicine and Biological Sciences, "Stefan cel Mare" University of Suceava, 13 Universitatii Str., 720229 Suceava, Romania.
Gabriela StefanescuFaculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Str., 700115 Iasi, Romania.ORCID 0000-0002-1394-8648
Smaranda DiaconescuFaculty of Medicine, "Titu Maiorescu" University of Medicine, 67A Gheorghe Petrascu Str., 031592 Bucharest, Romania.
Grigore T. Popa University of Medicine and Pharmacy · ROClinical Emergency Hospital Bucharest · ROŞtefan cel Mare University of Suceava · ROCarol Davila University of Medicine and Pharmacy · ROTitu Maiorescu University · ROUniversitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș · RO
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
background
methodsWe studied 84 positive gastric samples for
resultsOf the 84 biopsy samples analyzed, 35 (41.6%) were resistant to clarithromycin. Clarithromycin resistance was found mainly in girls (80%) with a mean age of 15 years (range 6-17 years). The history of prior exposure to clarithromycin was 91.6%. The concordance between the histopathological examination and the PCR test was 100%.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Pattern of Primary Resistance of · full record | OpenQuestion